3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
1
Attention Deficit Disorder with Hyperactivity
1
Interventions
Bevacizumab
3
durvalumab
2
atezolizumab
2
Hepatectomy
2
tremelimumab
1
trastuzumab deruxtecan
1
pembrolizumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radionuclide Imaging
1
Platinum
1
Ipilimumab
1
Immunotherapy
1
Immunoglobulin G
1
Immune Checkpoint Inhibitors
1
IMC-001
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Cell- and Tissue-Based Therapy
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
N-monoacetylcystine
×
30 days
×
Clear all
No trials found.